daunosamine has been researched along with aclarubicin in 1 studies
| Studies (daunosamine) | Trials (daunosamine) | Recent Studies (post-2010) (daunosamine) | Studies (aclarubicin) | Trials (aclarubicin) | Recent Studies (post-2010) (aclarubicin) |
|---|---|---|---|---|---|
| 32 | 0 | 5 | 826 | 97 | 105 |
| Protein | Taxonomy | daunosamine (IC50) | aclarubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 9.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahne, D; Leimkuhler, C; Lu, W; Oberthür, M; Walsh, CT | 1 |
1 other study(ies) available for daunosamine and aclarubicin
| Article | Year |
|---|---|
AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.
Topics: Aclarubicin; Catalysis; Cloning, Molecular; Fucose; Fucosyltransferases; Glycosylation; Hexosamines; Naphthacenes; Streptomyces; Substrate Specificity; Thymine Nucleotides; Trisaccharides | 2004 |